0001567619-23-000905.txt : 20230112
0001567619-23-000905.hdr.sgml : 20230112
20230112213136
ACCESSION NUMBER: 0001567619-23-000905
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230110
FILED AS OF DATE: 20230112
DATE AS OF CHANGE: 20230112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cooke Shane
CENTRAL INDEX KEY: 0001524823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35676
FILM NUMBER: 23527030
MAIL ADDRESS:
STREET 1: TREASURY BUILDING LOWER GRAND CANAL ST.
CITY: DUBLIN 2
STATE: L2
ZIP: 00000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTHENA CORP PUBLIC LTD CO
CENTRAL INDEX KEY: 0001559053
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 77 SIR JOHN ROGERSON'S QUAY, BLOCK C
STREET 2: GRAND CANAL DOCKLANDS
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
BUSINESS PHONE: 011-353-1-236-2500
MAIL ADDRESS:
STREET 1: 77 SIR JOHN ROGERSON'S QUAY, BLOCK C
STREET 2: GRAND CANAL DOCKLANDS
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
FORMER COMPANY:
FORMER CONFORMED NAME: Prothena Corp plc
DATE OF NAME CHANGE: 20121102
FORMER COMPANY:
FORMER CONFORMED NAME: Neotope Corp Ltd
DATE OF NAME CHANGE: 20120926
4
1
doc1.xml
FORM 4
X0306
4
2023-01-10
0
0001559053
PROTHENA CORP PUBLIC LTD CO
PRTA
0001524823
Cooke Shane
C/O PROTHENA BIOSCIENCES INC
331 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Ordinary Shares, par value $0.01 per share
2023-01-10
4
M
0
5000
6.41
A
5000
D
Ordinary Shares, par value $0.01 per share
2023-01-10
4
S
0
5000
52.9216
D
0
D
Stock Option (Right to Buy)
6.41
2023-01-10
4
M
0
5000
0
D
2014-01-29
2023-01-29
Ordinary Shares
5000
0
D
The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The transaction was executed in multiple trades in prices ranging from $52.28 to $53.175, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 2 of this Form 4.
The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023.
/s/ Michael Malecek, as Attorney in Fact for Shane M. Cooke
2023-01-12